1. Home
  2. APLS vs STRA Comparison

APLS vs STRA Comparison

Compare APLS & STRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • STRA
  • Stock Information
  • Founded
  • APLS 2009
  • STRA 2017
  • Country
  • APLS United States
  • STRA United States
  • Employees
  • APLS N/A
  • STRA N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • STRA Other Consumer Services
  • Sector
  • APLS Health Care
  • STRA Real Estate
  • Exchange
  • APLS Nasdaq
  • STRA Nasdaq
  • Market Cap
  • APLS 2.2B
  • STRA 2.0B
  • IPO Year
  • APLS 2017
  • STRA 1996
  • Fundamental
  • Price
  • APLS $16.93
  • STRA $91.23
  • Analyst Decision
  • APLS Buy
  • STRA Strong Buy
  • Analyst Count
  • APLS 19
  • STRA 3
  • Target Price
  • APLS $37.50
  • STRA $112.67
  • AVG Volume (30 Days)
  • APLS 2.9M
  • STRA 182.2K
  • Earning Date
  • APLS 05-07-2025
  • STRA 04-24-2025
  • Dividend Yield
  • APLS N/A
  • STRA 2.63%
  • EPS Growth
  • APLS N/A
  • STRA 11.28
  • EPS
  • APLS N/A
  • STRA 4.68
  • Revenue
  • APLS $775,839,000.00
  • STRA $1,233,270,000.00
  • Revenue This Year
  • APLS $1.54
  • STRA $6.07
  • Revenue Next Year
  • APLS $22.80
  • STRA $5.02
  • P/E Ratio
  • APLS N/A
  • STRA $19.49
  • Revenue Growth
  • APLS 48.04
  • STRA 5.72
  • 52 Week Low
  • APLS $16.10
  • STRA $74.28
  • 52 Week High
  • APLS $43.76
  • STRA $121.60
  • Technical
  • Relative Strength Index (RSI)
  • APLS 41.44
  • STRA 65.91
  • Support Level
  • APLS $16.61
  • STRA $86.12
  • Resistance Level
  • APLS $17.48
  • STRA $90.97
  • Average True Range (ATR)
  • APLS 0.86
  • STRA 1.87
  • MACD
  • APLS 0.09
  • STRA 0.02
  • Stochastic Oscillator
  • APLS 28.47
  • STRA 93.82

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

Share on Social Networks: